Evaluation and Management of Soft, Foul-Smelling Stools in UC Without Diarrhea
You should first measure fecal calprotectin, CRP, or fecal lactoferrin to determine if active inflammation is present, as soft stools with altered odor can represent mild UC activity even without frank diarrhea. 1
Initial Diagnostic Approach
Your symptom pattern—soft, fluffy, malodorous stools without true diarrhea—represents a mild symptom presentation that requires objective assessment before treatment decisions. The 2023 AGA guidelines are explicit about this scenario.
Step 1: Biomarker Testing
Obtain fecal calprotectin, fecal lactoferrin, or serum CRP to distinguish between:
- Active inflammation requiring treatment escalation
- Non-inflammatory symptoms (functional overlay, bile acid malabsorption, SIBO, dietary factors)
Critical thresholds 1:
- Fecal calprotectin >150 mg/g suggests active inflammation
- Elevated fecal lactoferrin or CRP similarly indicates inflammation
- Normal biomarkers (<150 mg/g calprotectin) make moderate-to-severe inflammation unlikely
Step 2: Interpretation and Next Steps
If biomarkers are elevated (calprotectin >150 mg/g):
- Proceed to endoscopic assessment rather than empirically escalating therapy 1
- This confirms whether mucosal inflammation is present and guides treatment decisions
- Rule out Clostridioides difficile and other enteric pathogens, as biomarkers can be elevated from non-IBD causes 1
If biomarkers are normal:
- Endoscopic assessment is still recommended for mild symptoms with normal biomarkers 1
- However, if you prefer to avoid immediate endoscopy, repeat biomarkers in 3-6 months is a reasonable alternative 1
- Consider alternative causes (see below)
Alternative Pathophysiologic Mechanisms
Since your stools are soft and malodorous but not liquid diarrhea, consider these non-inflammatory causes 2:
- Bile acid malabsorption - particularly if you have ileal disease or prior resection
- Small intestinal bacterial overgrowth (SIBO) - can cause soft, foul-smelling stools
- Carbohydrate intolerance (lactose, fructose) - produces gas, bloating, and soft stools
- Dietary factors - high FODMAP foods can cause similar symptoms
Stool consistency matters: Recent evidence shows that Bristol Stool Form Scale type 6-7 (mushy/liquid) is independently associated with active disease, even in endoscopic remission 3. Your "soft fluffy" description likely corresponds to Bristol type 5-6, which warrants investigation.
Management Algorithm
If Active Inflammation is Confirmed:
- Start or optimize oral 5-ASA 2-4 g/day combined with topical 5-ASA (enemas/suppositories)
- If no response in 2-4 weeks, add prednisolone 40 mg daily, tapering over 6-8 weeks
- If you've required ≥2 steroid courses in the past year, consider treatment escalation to thiopurines, anti-TNF, vedolizumab, or JAK inhibitors 4
If No Active Inflammation (Functional Symptoms):
Symptomatic management 2:
- Bile acid sequestrants (cholestyramine) for chronic loose stools in quiescent UC
- Low FODMAP diet trial with dietitian supervision
- Probiotics may be considered
- Avoid opiates for any associated discomfort
Critical Pitfalls to Avoid
Don't assume symptoms = inflammation: Up to 34% of patients with bowel urgency have endoscopic remission 3. Soft stools can persist despite mucosal healing.
Don't empirically escalate therapy without objective evidence: The AGA explicitly recommends against this for mild symptoms 1
Don't ignore infection: Always test for C. difficile and enteric pathogens when biomarkers are elevated 1
Don't overlook functional overlap: Histologic inflammation and stool form are independent predictors of symptoms, even with endoscopic remission 3
Monitoring Strategy
If you proceed with biomarker monitoring rather than immediate endoscopy:
- Repeat fecal calprotectin in 3-6 months 1
- If persistently elevated on repeat testing, endoscopy becomes necessary
- Serial monitoring allows anticipatory management and may catch subclinical flares 2
The key principle: Combine symptoms with objective biomarkers rather than relying on symptoms alone to guide treatment decisions 1. Your unusual stool pattern warrants investigation, not assumption.